Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator. - Singh, Dave; Balaguer, Victor; Astbury, Carol; Wählby-Hamrén, Ulrika; Jimenez, Eulalia; Seoane, Beatriz; Villarroel, Cristina; Lei, Alejhandra; Aggarwal, Ajay; Psallidas, Ioannis (Respiratory Research, 2020)